PRIME Horizon2020

PRIME Horizon2020

Forschungsdienstleistungen

We investigate the role of insulin-signaling in major somatic and brain disorders

Info

PRIME is a European consortium of research institutes, medical centres, companies, and societal stakeholders that is funded through an EU Horizon 2020 grant. From 2020 – 2024, PRIME will aim to unravel the insulin-dependent mechanisms that underly both somatic conditions (i.e. type 2 diabetes, obesity, metabolic syndrome) and brain disorders (i.e. Alzheimer’s disease, obsessive-compulsive disorder, autism spectrum disorders). Until now, very little attention has been paid to the role of insulin signaling in brain disorders, and the overlap (or ‘multimorbidity’) with somatic conditions. Therefore, through PRIME, we aim to develop tools for improved diagnosis, clinical care and prevention of insulin-related lifespan multimorbidity.

Branche
Forschungsdienstleistungen
Größe
51–200 Beschäftigte
Hauptsitz
Fürstenfeldbruck
Art
Nonprofit
Gegründet
2020
Spezialgebiete
research, insulin, Alzheimer's disease, type 2 diabetes, metabolic syndrome, obesity, obsessive compulsive disorder, autism spectrum disorders, genetics, animal models, dissemination, epidemiology und clinical guidelines

Orte

Beschäftigte von PRIME Horizon2020

Updates

Ähnliche Seiten

Jobs durchsuchen